Pulmonx (LUNG) Net Cash Flow (2019 - 2025)

Pulmonx (LUNG) has 7 years of Net Cash Flow data on file, last reported at $692000.0 in Q3 2025.

• On a quarterly basis, Net Cash Flow rose 6820.0% year-over-year to $692000.0 in Q3 2025; TTM through Dec 2025 was $6.0 million, a 147.04% increase from a year earlier, with the FY2024 full-year figure at -$12.7 million, up 30.3% from the prior year.
• Net Cash Flow for Q3 2025 stood at $692000.0, down from $1.5 million in the prior quarter.
• Over the last five years, Net Cash Flow for LUNG reached as high as $8.7 million in Q1 2023 and fell as low as -$39.7 million in Q4 2021.
• Historically, Net Cash Flow has averaged -$8.2 million across 5 years, with a median of -$8.6 million in 2023.
• Across the five-year window, Net Cash Flow sank 1550.26% in 2021 and soared 6820.0% in 2025, its largest moves.
• Year by year, Net Cash Flow stood at -$39.7 million in 2021, then jumped by 73.61% to -$10.5 million in 2022, then dropped by 6.89% to -$11.2 million in 2023, then soared by 166.08% to $7.4 million in 2024, then tumbled by 90.64% to $692000.0 in 2025.
• Per Business Quant data, the three most recent Net Cash Flow figures were $692000.0 in Q3 2025, $1.5 million in Q2 2025, and $3.8 million in Q1 2025.